FastBack Bio
PrivateCompany Overview
FastBack Bio operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. It was founded in 2020.
FastBack Bio is a biotechnology company with a novel CAR-T platform to develop T cell-based therapeutics and gene therapies to cure cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FastBack Bio Comparables
Compare FastBack Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inceptor Bio | 86% | |
| AffyImmune Therapeutics | 77% | |
| Roche Holding | 70% |
For institutional investors. Book with your work email.
FastBack Bio Funding Rounds
Historical fundraising activity
FastBack Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FastBack Bio's valuation, stock price, and market status.
Is FastBack Bio a public or private company?
FastBack Bio is a private company.
What is the current stock price of FastBack Bio?
FastBack Bio is a private company, so its shares have no public market price. Caplight tracks FastBack Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FastBack Bio worth (valuation)?
Valuation information for FastBack Bio is not publicly available.
Can I buy FastBack Bio stock?
FastBack Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FastBack Bio's last funding round?
Funding round information for FastBack Bio is not publicly available.
Who are the main investors in FastBack Bio?
Investor information for FastBack Bio is not publicly disclosed.
Will FastBack Bio IPO soon?
No public IPO plans have been announced for FastBack Bio.
How can I track FastBack Bio secondary market activity?
Caplight tracks bids, offers, and trades in FastBack Bio's shares on secondary markets.